NCT05392699View on ClinicalTrials.gov

ABOD2011 in Patients With Advanced Solid Tumors Progressed After Standard Systemic Therapy

PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 25, 2022

Primary Completion Date

March 31, 2025

Study Completion Date

January 31, 2027

Conditions
Patients With Advanced Solid Tumors
Interventions
BIOLOGICAL

human single chain IL-12 mRNA-single dose

human single chain IL-12 mRNA administered as specified in the treatment arm with injection once only

BIOLOGICAL

human single chain IL-12 mRNA-multiple dose

human single chain IL-12 mRNA administered as specified in the treatment arm with injection once per week for 3 weeks

Trial Locations (1)

Unknown

RECRUITING

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing

All Listed Sponsors
lead

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER